Market Pulse63Bullish

Teladoc Health, Inc.Opportunity Rank #21(TDOC) Intrinsic Value & DCF Analysis (2026)

Sector: Healthcare

Current Price

$9.28

Last updated: Jul 13, 2026

Price vs Intrinsic Value

$9.28
Price
$50.58
Intrinsic Value
Undervalued by 445%MOS: $40.46

Fundamental Score

66/100
Bullish

Weighted across 6 signals

Narrative Score

59/100
Improving

No change vs previous

Trend Score

94/100
Strong

As of 2026-07-10

The intrinsic value of Teladoc Health, Inc. (TDOC) is estimated at $50.58 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $9.28, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 14.38% long-term growth rate and a 10.00% discount rate (calculated: 8.35%), reflecting expected future free cash flow and cost of capital.

The intrinsic value of Teladoc Health, Inc. (TDOC) is estimated at $50.58 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $9.28, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 14.38% long-term growth rate and a 10.00% discount rate (calculated: 8.35%), reflecting expected future free cash flow and cost of capital.

Valuation Details

$50.58
▲ 445.04% upside
20% margin of safety: $40.46
Years: 10Growth Rate: 14.38%
Want to create your own valuation? Create a free account.

Capital Efficiency

Average Quarterly ROIC
-2.11%
Cost of Capital (estimated)9%
Value StatusUnderperforming Capital

The company is earning below its required return. This may indicate inefficient use of capital or excess cash that isn't being reinvested.

Complete historical ROIC is available with
.

Fundamental Details

66/100
BullishWeighted across 6 signals
DCF Discount
445.0% discount to price
100
FCF Yield
19.4% trailing FCF yield
100
ROIC vs WACC
ROIC -2.1% vs WACC 9.0% (-0.2x)
0
Net Debt / FCF
0.8x net debt to FCF
85
Buybacks
Share count growing
30
FCF CAGR (5Y)
223.3% 5Y FCF CAGR (adjusted)
100
Strengths: DCF Discount, FCF Yield. Concerns: ROIC vs WACC, Buybacks.

Narrative Details

59/100
Improving
Vs 6-Month Baseline:High (93rd pct)Weighted across 4 recent drivers
Trend: Improving upConfidence: 72%Updated: 2d ago
Sources: 23 (21 News · 2 Analyst)
Drivers(last 30 days)
19 news sentiment+0.9
Earnings miss-0.0
Regulatory scrutiny+0.0
2 analyst reiterations0.0

Trend Details

94/100
StrongAs of 2026-07-10309 daily bars used
3M Relative Strength vs SPY+65.7%
Price vs 50 EMA+22.0%
21 EMA vs 50 EMA+10.9%
Price vs 21 EMA92 · +10.0%
Price vs 50 EMA98 · +22.0%
21 EMA vs 50 EMA97 · +10.9%
3M RS vs SPY100 · +65.7%
6M RS vs SPY81 · +13.1%
Distance from 52W High95 · -2.5%

Investment Coach

Updating... 32d ago
BUYConfidence: 54%
Thesis
Teladoc Health, Inc. (TDOC) presents a compelling buy opportunity with an estimated fair value 650.5% above its current price and strong free cash flow yield of 25.6%, supported by constructive fundamentals and improving narrative trends. Despite trailing returns relative to its cost of capital, the company's significant free cash flow growth and bullish fundamentals suggest potential for substantial upside.
Key Risk
The primary risk is the negative spread between ROIC and WACC, indicating returns are currently below the cost of capital.
Signals To Watch
  • Monitor whether valuation discount remains above 10%.
  • Track ROIC vs WACC spread for sustained improvement.
  • Follow narrative trend for meaningful shifts in the score direction.
Ask the Coach - Available with
Historical Growth Rates
Free Cash Flow- - -Trend CAGR: 14.54%5 Year CAGR: 9.91%

Free Cash Flow (in millions)

TTM2025202420232022202120202019201820172016201520142013
$325$303$304$506$206$203-$27$41$4-$29-$48-$39-$10-$5

How Intrinziq Estimates Fair Value

Intrinziq estimates Teladoc Health, Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.

Teladoc Health, Inc.Healthcare

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.